Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 39,732 shares at $82.53 ($3.3M) on 2019-11-15, disclosed to the SEC on 2019-11-19.
Open-market sale of $3.3M NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.53 | 6,100 | $503K | 15.1% |
| 2 | $83.52 | 12,461 | $1.0M | 31.3% |
| 3 | $83.52 | 12,461 | $1.0M | 31.3% |
| 4 | $84.01 | 1,439 | $121K | 3.6% |
| 5 | $84.01 | 1,439 | $121K | 3.6% |
| 6 | $85.35 | 1,800 |
| $154K |
| 4.6% |
| 7 | $86.08 | 3,132 | $270K | 8.1% |
| 8 | $86.93 | 900 | $78K | 2.4% |
| Total | $83.77 avg | 39,732 | $3.3M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |